The demerger allows for a sharper strategic focus, with Apollo Hospitals Enterprise Ltd. concentrating on core healthcare services, while NewCo drives growth in digital health and pharmacy distribution under dedicated leadership.
NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
The proposal to demerge the pharmacy business—including offline pharmacy, online and telehealth operations, and Kiemed—into NewCo bodes well for Apollo Hospitals Enterprises Ltd.'s long term value creation across both the healthcare services (hospital/clinics business) and pharmacy businesses.
In fact, acquiring the remaining 74.5% stake brings the front-end pharmacy operations fully under NewCo, enabling the creation of a complete ecosystem and positioning it as the largest omnichannel pharmacy distribution/digital health platform.
The demerger allows for a sharper strategic focus, with Apollo Hospitals concentrating on core healthcare services, while NewCo drives growth in digital health and pharmacy distribution under dedicated leadership.
We value Apollo Hospitals on an SoTP basis (30x EV/Ebitda for the hospital business, 15x EV/Ebitda for retained pharmacy, 23x EV/Ebitda for Apollo Health and Lifestyle Ltd., 22x EV/Ebitda for front-end pharmacy, and 2x EV/sales for Apollo 24/7) to arrive at our target price of Rs 8,720. Reiterate Buy.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
